Abbott India elevates Maithilee Pathare Mistry as CFO
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
The freshly infused capital will primarily be deployed towards expansion and research & development
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
CDMO business delivered high-teen revenue growth for 9MFY25 driven by continued traction in the on-patent commercial manufacturing and generic API business
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
Subscribe To Our Newsletter & Stay Updated